Iconthin Biotech is a Canadian biotechnology company specializing in algae-based ingredients and sustainable microalgae innovation. Our focus spans nutraceuticals, skincare, and functional food applications, with a mission to transform advanced biotechnology research into science-backed wellness solutions for modern consumers. At the core of our technology platform is AlgaeAsta®, our premium natural astaxanthin ingredient derived exclusively from the microalgae (Haematococcus pluvialis). Produced using advanced third-generation closed cultivation technology and solvent-free extraction methods, AlgaeAsta® is developed with a strong focus on purity, stability, safety, and bioavailability. Our innovation is further supported through collaboration with the University of Toronto’s microalgae research team, reflecting our long-term commitment to scientific advancement and sustainable biotechnology. Building on this foundation, Astadaily® was created as the premium consumer wellness brand under Iconthin Biotech. Crafted in Canada, Astadaily® combines advanced microalgae biotechnology with premium formulations designed to support daily wellness, healthy aging, eye health, skin wellness, recovery, and antioxidant protection. Through AlgaeAsta® and Astadaily®, Iconthin Biotech is committed to making high-quality natural astaxanthin more accessible to consumers seeking trusted, research-driven wellness solutions for long-term health and vitality.
Looking for a particular Iconthin Biotech employee's phone or email?
The Iconthin Biotech annual revenue was $5 million in 2026.
Alvin C. is the Founder and CEO of Iconthin Biotech.
4 people are employed at Iconthin Biotech.
Iconthin Biotech is based in Toronto, Ontario.
The NAICS codes for Iconthin Biotech are [54171, 5417, 541, 54, 541713].
The SIC codes for Iconthin Biotech are [873, 87].